UBS Group’s Zosano Pharma Corporation ZSAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,133
| Closed | -$32K | – | 11730 |
|
|
2022
Q1 | $32K | Buy |
4,133
+1,993
| +93% | +$21.9K | ﹤0.01% | 6949 |
|
|
2021
Q4 | $35K | Buy |
2,140
+1,863
| +673% | +$39.3K | ﹤0.01% | 7250 |
|
|
2021
Q3 | $7K | Sell |
277
-19
| -6% | -$493 | ﹤0.01% | 8384 |
|
|
2021
Q2 | $10K | Sell |
296
-228
| -44% | -$7.35K | ﹤0.01% | 8100 |
|
|
2021
Q1 | $23K | Sell |
524
-272
| -34% | -$11.4K | ﹤0.01% | 7268 |
|
|
2020
Q4 | $14K | Sell |
796
-2,975
| -79% | -$58.2K | ﹤0.01% | 7248 |
|
|
2020
Q3 | $214K | Buy |
3,771
+1,880
| +99% | +$87.5K | ﹤0.01% | 4760 |
|
|
2020
Q2 | $57K | Sell |
1,891
-964
| -34% | -$27.2K | ﹤0.01% | 5754 |
|
|
2020
Q1 | $56K | Buy |
2,855
+896
| +46% | +$30K | ﹤0.01% | 5753 |
|
|
2019
Q4 | $105K | Buy |
1,959
+945
| +93% | +$58.3K | ﹤0.01% | 5981 |
|
|
2019
Q3 | $55K | Sell |
1,014
-532
| -34% | -$47.7K | ﹤0.01% | 6154 |
|
|
2019
Q2 | $177K | Buy |
1,546
+760
| +97% | +$89.9K | ﹤0.01% | 4989 |
|
|
2019
Q1 | $131K | Buy |
786
+572
| +267% | +$70.1K | ﹤0.01% | 4883 |
|
|
2018
Q4 | $16K | Buy |
214
+91
| +74% | +$11.5K | ﹤0.01% | 6966 |
|
|
2018
Q3 | $17K | Buy |
+123
| New | +$18K | ﹤0.01% | 6902 |
|
|
2018
Q2 | – | Sell |
-7
| Closed | -$1K | – | 8367 |
|
|
2018
Q1 | $1K | Sell |
7
-13
| -65% | -$4.35K | ﹤0.01% | 7687 |
|
|
2017
Q4 | $7K | Buy |
20
+16
| +400% | +$8.03K | ﹤0.01% | 7261 |
|
|
2017
Q3 | $2K | Hold |
4
| – | – | ﹤0.01% | 7511 |
|
|
2017
Q2 | $4K | Buy |
4
+2
| +100% | +$2.06K | ﹤0.01% | 7238 |
|
|
2017
Q1 | $3K | Buy |
+2
| New | +$2.41K | ﹤0.01% | 7220 |
|
|
2016
Q2 | – | Hold |
0
| – | -$1K | – | 8073 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | -$1.65K | – | 7485 |
|
|
2015
Q4 | $2K | Buy |
+1
| New | +$1.95K | ﹤0.01% | 8052 |
|
|
2015
Q3 | – | Sell |
-1
| Closed | -$6K | – | 8748 |
|
|
2015
Q2 | $6K | Hold |
1
| – | – | ﹤0.01% | 7809 |
|
|
2015
Q1 | $9K | Buy |
+1
| New | +$7.5K | ﹤0.01% | 7750 |
|
Other funds holding ZSAN
UBS Group's ZSAN Position: Q2 2022 in Review
UBS Group sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 4,133 shares — an estimated $32K sold.
UBS Group first reported a position in ZSAN in Q1 2015 and held it in 23 quarters. The position peaked at $214K in Q3 2020. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.
- UBS Group reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
- UBS Group sold 4,133 Zosano Pharma Corporation shares in Q2 2022, an estimated $32K.
- UBS Group first reported a position in Zosano Pharma Corporation in Q1 2015 and held it in 23 quarters.
- UBS Group's Zosano Pharma Corporation position peaked at $214K in Q3 2020.
- 3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.
Based on UBS Group's 13F filing for Q2 2022, filed 10 Aug 2022.